These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9818032)

  • 1. Preferential binding of E7010 to murine beta 3-tubulin and decreased beta 3-tubulin in E7010-resistant cell lines.
    Iwamoto Y; Nishio K; Fukumoto H; Yoshimatsu K; Yamakido M; Saijo N
    Jpn J Cancer Res; 1998 Sep; 89(9):954-62. PubMed ID: 9818032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
    Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
    Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeletons and antimitotic agents developed in Japan.
    Nishio K; Saijo N
    Anticancer Drug Des; 1999 Apr; 14(2):133-41. PubMed ID: 10405640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.
    Wang W; Zhang H; Wang X; Patterson J; Winter P; Graham K; Ghosh S; Lee JC; Katsetos CD; Mackey JR; Tuszynski JA; Wong GK; Ludueña RF
    Protoplasma; 2017 May; 254(3):1163-1173. PubMed ID: 27943021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational States of E7010 Is Complemented by Microclusters of Water Inside the α,β-Tubulin Core.
    Majumdar S; Basu D; Ghosh Dastidar S
    J Chem Inf Model; 2019 May; 59(5):2274-2286. PubMed ID: 30516382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis.
    Yokoi A; Kuromitsu J; Kawai T; Nagasu T; Sugi NH; Yoshimatsu K; Yoshino H; Owa T
    Mol Cancer Ther; 2002 Feb; 1(4):275-86. PubMed ID: 12467223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Isonishi S; Saitou M; Saitou M; Yasuda M; Tanaka T
    Oncol Rep; 2007 Jul; 18(1):195-201. PubMed ID: 17549368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 17). Testicular toxicity of E7010, a sulfonamide tubulin polymerization inhibitor.
    Hayakawa K; Tashiro T; Sato K; Katsurayama T; Imai T; Hosokawa S; Sagami F
    J Toxicol Sci; 2000 Oct; 25 Spec No():173-8. PubMed ID: 11349441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S; McCauley RA; Dexter DW; Hudes GR
    Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
    Nicoletti MI; Valoti G; Giannakakou P; Zhan Z; Kim JH; Lucchini V; Landoni F; Mayo JG; Giavazzi R; Fojo T
    Clin Cancer Res; 2001 Sep; 7(9):2912-22. PubMed ID: 11555610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance.
    Ranganathan S; Dexter DW; Benetatos CA; Chapman AE; Tew KD; Hudes GR
    Cancer Res; 1996 Jun; 56(11):2584-9. PubMed ID: 8653701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of E7010.
    Yamamoto K; Noda K; Yoshimura A; Fukuoka M; Furuse K; Niitani H
    Cancer Chemother Pharmacol; 1998; 42(2):127-34. PubMed ID: 9654112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance.
    Haber M; Burkhart CA; Regl DL; Madafiglio J; Norris MD; Horwitz SB
    J Biol Chem; 1995 Dec; 270(52):31269-75. PubMed ID: 8537394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol.
    Kavallaris M; Burkhart CA; Horwitz SB
    Br J Cancer; 1999 Jun; 80(7):1020-5. PubMed ID: 10362110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
    Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
    Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-(m-Azidobenzoyl)taxol binds differentially to distinct β-tubulin isotypes.
    Yang CH; Yap EH; Xiao H; Fiser A; Horwitz SB
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11294-11299. PubMed ID: 27651486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.
    Giannakakou P; Sackett DL; Kang YK; Zhan Z; Buters JT; Fojo T; Poruchynsky MS
    J Biol Chem; 1997 Jul; 272(27):17118-25. PubMed ID: 9202030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of beta-tubulin mRNA and protein levels in 12 human cancer cell lines.
    Hiser L; Aggarwal A; Young R; Frankfurter A; Spano A; Correia JJ; Lobert S
    Cell Motil Cytoskeleton; 2006 Jan; 63(1):41-52. PubMed ID: 16362954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
    Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
    Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.